Thomas G. Wiggans is CEO & Chairman at Dermira, Inc. (DERM). They have made 40 open-market trades across 5 companies since 2006, most recently 2025-09-22.
CIK 0001208907
15 open-market purchases totalling $1.5M since 2006, against 25 sales. Across 11 scored buys the stock is up 62.9% at ninety days, and 56.8 points ahead of the S&P over the same stretch.
11 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 0% | 73% | 91% |
| Avg Move | -7.1% | +17.2% | +62.9% |
| Alpha | -38.3% | +15.0% | +56.8% |
| Scored | 11 | 11 | 11 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| JSPR | BUY | 2025-09-22 | 2025-09-24 | $2.43 | $100K | -4.0% | -5.2% | -27.6% |
| JSPR | BUY | 2023-11-28 | 2023-11-30 | $0.65 | $7K | -27.5% | +9.8% | +222.6% |
| JSPR | BUY | 2023-11-21 | 2023-11-22 | $0.64 | $6K | -7.7% | -18.8% | +203.8% |
| JSPR | BUY | 2023-11-16 | 2023-11-20 | $0.61 | $18K | -3.1% | -14.3% | +201.4% |
| PRDS | BUY | 2022-12-05 | 2022-12-07 | $1.09 | $14K | -0.9% | +107.5% | +27.1% |
| PRDS | BUY | 2022-12-01 | 2022-12-05 | $1.05 | $39K | -6.5% | +63.7% | +18.5% |
| DERM | BUY | 2019-08-19 | 2019-08-19 | $8.54 | $400K | -5.7% | +9.2% | +9.2% |
| DERM | BUY | 2018-07-09 | 2018-07-09 | $10.00 | $120K | -5.7% | +9.2% | +9.2% |
| DERM | BUY | 2018-07-02 | 2018-07-02 | $8.71 | $240K | -5.7% | +9.2% | +9.2% |
| DERM | BUY | 2018-06-25 | 2018-06-25 | $9.84 | $120K | -5.7% | +9.2% | +9.2% |
| DERM | BUY | 2018-06-18 | 2018-06-18 | $10.10 | $240K | -5.7% | +9.2% | +9.2% |
| DERM | SELL | 2017-12-13 | 2017-12-15 | $27.51 | $138K | -5.7% | +9.2% | +9.2% |
| DERM | SELL | 2017-11-02 | 2017-11-03 | $27.52 | $138K | -5.7% | +9.2% | +9.2% |
| DERM | SELL | 2017-10-10 | 2017-10-11 | $27.52 | $138K | -5.7% | +9.2% | +9.2% |
| DERM | SELL | 2017-09-18 | 2017-09-19 | $27.51 | $523K | -5.7% | +9.2% | +9.2% |
| DERM | SELL · 10b5-1 | 2017-08-01 | 2017-08-02 | $27.58 | $14K | -5.7% | +9.2% | +9.2% |
| DERM | SELL | 2017-07-03 | 2017-07-05 | $29.06 | $145K | -5.7% | +9.2% | +9.2% |
| DERM | SELL | 2017-06-01 | 2017-06-05 | $27.51 | $244K | -5.7% | +9.2% | +9.2% |
| DERM | SELL | 2017-05-01 | 2017-05-03 | $33.66 | $269K | -5.7% | +9.2% | +9.2% |
| DERM | SELL | 2017-04-03 | 2017-04-04 | $33.44 | $488K | -5.7% | +9.2% | +9.2% |
| DERM | SELL | 2017-03-03 | 2017-03-07 | $37.60 | $150K | -5.7% | +9.2% | +9.2% |
| DERM | SELL | 2017-03-01 | 2017-03-02 | $33.64 | $516K | -5.7% | +9.2% | +9.2% |
| DERM | SELL | 2017-02-01 | 2017-02-03 | $29.34 | $287K | -5.7% | +9.2% | +9.2% |
| DERM | SELL | 2017-01-03 | 2017-01-05 | $31.06 | $248K | -5.7% | +9.2% | +9.2% |
| DERM | SELL | 2016-12-01 | 2016-12-02 | $30.80 | $678K | -5.7% | +9.2% | +9.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| CNCT |
| 261,514 |
| — |
| Total | $520K |
Shares reported on the most recent Form 4, priced at the 2025-09-24 close. 4 holdings could not be priced and are excluded from the total.